Meetings

Meeting Announcements

Is “stressed” really “desserts” spelled backwards? How more objective assessment of eating behavior can refine our understanding of stress eating

Brain & Behavior Research Foundation
Meeting Announcement

The Brain & Behavior Research Foundation (BBRF) welcomes the public to join a free webinar, “Is “Stressed” Really “Desserts” Spelled Backwards? How More Objective Assessment of Eating Behavior Can Refine Our Understanding of Stress Eating” on Tuesday, May 13, 2025, at 2:00 pm ET. Kristin N. Javaras, D.Phil., Ph.D., Assistant Psychologist, Division of Women’s Mental Health at McLean Hospital and Assistant Professor of Psychology, Department of Psychiatry at Harvard Medical School will be the guest speaker. The session will be hosted by Jeffrey Borenstein, M.D., President & CEO of the Brain & Behavior Research Foundation and host of the Emmy® nominated television series Healthy Minds.

Ready to Launch Program to spotlight careers in interventional cardiology at SCAI Scientific Sessions 2025

Society for Cardiovascular Angiography and Interventions
Meeting Announcement

WASHINGTON— The Society for Cardiovascular Angiography & Interventions (SCAI) once again hosted its flagship outreach initiative, “Ready to Launch: Careers in Cardiology,” on Saturday, May 3, 2025, during the 2025 SCAI Scientific Sessions in Washington, DC.

New studies highlight potential of artificial intelligence to improve outcomes for patients with heart failure and cardiac arrest

Society for Cardiovascular Angiography and Interventions
Meeting Announcement

Washington, D.C. – May 2, 2025 – New research elevates the use of artificial intelligence (AI) for safer, accessible, and efficient detection and treatment for patients with heart failure and cardiac arrest. The data were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions.

Novel, balloon-assisted anterior mitral leaflet modification shown to be safe and effective for patients undergoing transcatheter mitral valve replacement

Society for Cardiovascular Angiography and Interventions
Meeting Announcement

Washington, D.C. – MAY 2, 2025 – New data from a large, international registry showed balloon-assisted anterior mitral leaflet modification (BATMAN) was safe, effective, and resulted in shorter procedure times among patients undergoing transcatheter mitral valve replacement (TMVR).

Younger patients with asymptomatic aortic stenosis who undergo transcatheter aortic valve replacement experience lower rates of serious cardiovascular events, including stroke

Society for Cardiovascular Angiography and Interventions
Meeting Announcement

Washington, D.C. – May 2, 2025 – New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a strategy of early intervention with transcatheter aortic valve replacement (TAVR) compared to other age groups, especially in regards to stroke risk, and in regards to the composite of death, stroke, and heart failure hospitalization.

Novel innovations effectively and safely enable improved blood flow in high-risk patients

Society for Cardiovascular Angiography and Interventions
Meeting Announcement

Washington, D.C. – May 1, 2025 – New technology shows promise for restoring blood flow and advancing care for patients with pulmonary embolism (PE) and carotid artery stenosis (CAS).

By 2030, 40% increase in tobacco-related coronary heart disease deaths anticipated

Society for Cardiovascular Angiography and Interventions
Meeting Announcement

Washington, D.C. – May 1, 2025 – New clinical results from multiple studies show coronary heart disease death associated with tobacco use is anticipated to rise up to 40% in the next five years and people with cannabis use disorder are 50% more likely to experience cardiogenic shock, acute myocardial infarction, and arrhythmias.

Press registration and scientific program now available for atomic, molecular, and optical physics meeting

American Physical Society
Meeting Announcement

More than 1,200 physicists from around the world will convene to present new research at the 56th Annual Meeting of the American Physical Society’s Division of Atomic, Molecular and Optical Physics. The conference will be held in person only at the Oregon Convention Center in Portland, Oregon June 16-20.

Smart science, real solutions: ACC Asia 2025 tackles heart health challenges across Asia

American College of Cardiology
Meeting Announcement

The American College of Cardiology (ACC) and the Singapore Cardiac Society (SCS) will host the ACC Asia 2025 Together with SCS 36^th Annual Scientific Meeting on May 9-11 in Singapore. The conference will bring together leading experts and cardiovascular clinicians from across Asia to examine emerging trends and evidence-based strategies in the prevention and management of patients with heart disease.

Alarming rise in cardiovascular deaths for those with obesity disproportionately impacting minorities and women

Society for Cardiovascular Angiography and Interventions
Meeting Announcement

Washington, D.C. – May 1, 2025 – New data highlights juxtaposing trends in serious obesity-related cardiovascular events. A recent study details the obesity paradox in patients with critical limb ischemia (CLI), demonstrating lower mortality in patients with obesity by 50% compared to non-obese patients.

GLP-1 studies add to growing body of evidence demonstrating significant benefit on cardiovascular outcomes

Society for Cardiovascular Angiography and Interventions
Meeting Announcement

Washington, D.C. – May 1, 2025 – New findings from multiple studies demonstrate that glucagon-like peptide-1 receptor agonists (GLP-1RAs), a class of medications used to treat type 2 diabetes, play a significant role in improving cardiovascular outcomes like heart failure (HF), acute myocardial infarction (AMI), peripheral artery disease (PAD), and ST-elevation myocardial infarction (STEMI).

Most Appropriate Pathway to Revascularize Using Angiography-Derived Fractional Flow Reserve (Quantitative Flow Ratio) to Guide Percutaneous Coronary Intervention (PCI)

Society for Cardiovascular Angiography and Interventions
Meeting Announcement

Washington, D.C. – May 1, 2025 – New findings from FAVOR III China Trial, presented today as late-breaking science at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions, showed that machine learning-based approach identify top 10 prognostic factors for predicting 2-year major adverse cardiovascular events (MACE) after Quantitative Flow Ratio (QFR)-guided Percutaneous Coronary Intervention (PCI) and therefore may improve individual risk prediction.

43
44
45
46
47